Na An Selected Research

Stimuli Responsive Polymers

11/2022

Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Na An Research Topics

Disease

46	Neoplasms (Cancer) 11/2022 - 03/2009
9	Multiple Myeloma 12/2020 - 03/2006
8	Inflammation (Inflammations) 01/2022 - 04/2011
7	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2011
7	Glioma (Gliomas) 08/2013 - 06/2010
5	Ovarian Neoplasms (Ovarian Cancer) 05/2022 - 04/2008
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2015
5	Carcinogenesis 01/2021 - 10/2011
4	Cardiotoxicity 11/2022 - 01/2020
4	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2019
3	Myocardial Ischemia (Ischemic Heart Diseases) 05/2022 - 01/2019
3	Heart Failure 05/2022 - 01/2019
3	Infections 02/2022 - 07/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 12/2016
3	Breast Neoplasms (Breast Cancer) 03/2021 - 01/2014
3	Atrophy 01/2021 - 04/2009
3	Necrosis 01/2021 - 01/2019
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 12/2016
3	Shock 01/2021 - 01/2008
3	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 04/2009
3	Leukemia 01/2018 - 03/2015
3	Glioblastoma (Glioblastoma Multiforme) 05/2012 - 06/2010
2	Ischemia 05/2022 - 01/2021
2	Hypoxia (Hypoxemia) 01/2022 - 01/2020
2	Stroke (Strokes) 01/2022 - 01/2019
2	Ischemic Stroke 01/2022 - 01/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2019
2	Oropharyngeal Neoplasms 12/2021 - 01/2021
2	Hemorrhage 11/2021 - 01/2014
2	Liver Neoplasms (Liver Cancer) 10/2021 - 01/2020
2	Sepsis (Septicemia) 01/2021 - 01/2008
2	Hyperthermia 01/2021 - 01/2018
2	Hypertension (High Blood Pressure) 01/2021 - 10/2020
2	Body Weight (Weight, Body) 01/2021 - 05/2014
2	Insulin Resistance 01/2021 - 07/2007
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2020 - 03/2015
2	Atherosclerosis 01/2020 - 10/2015
2	Hypertrophy 01/2020 - 01/2020
2	Fibrosis (Cirrhosis) 01/2020 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 05/2019 - 01/2018
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 02/2010
2	Prostatitis 11/2015 - 03/2015
2	Periodontitis 01/2014 - 02/2009
2	Ovarian Epithelial Carcinoma 02/2011 - 04/2008
2	Pre-Eclampsia (Preeclampsia) 10/2010 - 07/2007
2	Gram-Negative Bacterial Infections 12/2008 - 01/2008
2	Endotoxemia 12/2008 - 07/2008
1	Ventricular Remodeling 05/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2011
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2010
8	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2018
6	Pharmaceutical PreparationsIBA 09/2021 - 07/2008
5	Long Noncoding RNAIBA 01/2022 - 05/2018
4	Biological ProductsIBA 01/2022 - 05/2012
4	CytokinesIBA 01/2021 - 01/2008
4	CateninsIBA 01/2020 - 10/2011
4	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2012 - 07/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2020
3	Therapeutic UsesIBA 01/2022 - 08/2013
3	BerberineIBA 01/2022 - 03/2015
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 02/2010
3	Chimeric Antigen ReceptorsIBA 10/2018 - 03/2016
3	Retinaldehyde (Retinal)IBA 01/2016 - 04/2009
3	EnzymesIBA 02/2015 - 06/2010
2	Ribosomal DNA (rDNA)IBA 02/2022 - 01/2021
2	AntioxidantsIBA 01/2022 - 03/2015
2	Ethylene Glycol (Monoethylene Glycol)IBA 03/2021 - 08/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 03/2021 - 12/2016
2	LipopolysaccharidesIBA 01/2021 - 01/2008
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021 - 06/2017
2	AntigensIBA 01/2021 - 03/2016
2	Histones (Histone)IBA 01/2021 - 10/2020
2	Insulin (Novolin)FDA Link 01/2021 - 05/2014
2	LuciferasesIBA 01/2021 - 01/2014
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2018
2	Circular RNAIBA 01/2020 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2019
2	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 12/2016 - 02/2015
2	Amyloid (Amyloid Fibrils)IBA 01/2016 - 04/2011
2	Nicotine FDA Link 10/2015 - 01/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2015 - 08/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2014 - 03/2006
2	Matrix Metalloproteinases (MMPs)IBA 08/2013 - 03/2012
2	isocitric acid (isocitrate)IBA 05/2012 - 06/2010
2	Scorpion Venoms (Scorpion Venom)IBA 05/2012 - 01/2012
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2012 - 06/2010
1	HydrogelsIBA 11/2022
1	MicellesIBA 11/2022
1	Liposomes (Liposome)IBA 11/2022
1	Drug CarriersIBA 11/2022
1	Dendrimers (Dendrons)IBA 11/2022
1	Stimuli Responsive PolymersIBA 11/2022

Therapy/Procedure

30	Therapeutics 05/2022 - 03/2006
12	Drug Therapy (Chemotherapy) 11/2022 - 02/2011
5	Phototherapy (Light Therapy) 12/2021 - 01/2019
3	Immunotherapy 01/2021 - 01/2021
2	Combination Drug Therapy (Combination Chemotherapy) 03/2015 - 04/2014
2	Cytoreduction Surgical Procedures 02/2011 - 04/2008